SPY441.40-4.34 -0.97%
DIA345.64-1.80 -0.52%
IXIC15,043.97-137.96 -0.91%

Merck begins late-stage trial of experimental COVID-19 drug

reuters.com · 09/01/2021 06:51
Merck begins late-stage trial of experimental COVID-19 drug

- Merck & Co Inc MRK and partner Ridgeback Biotherapeutics said on Wednesday they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of COVID-19 infection.


(Reporting by Manas Mishra in Bengaluru; Editing by Krishna Chandra Eluri)

((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709;))